Charles Evan Ballantyne - 10 Apr 2023 Form 3 Insider Report for Gain Therapeutics, Inc. (GANX)

Signature
/s/ Cathy Rude, Attorney-in-Fact
Issuer symbol
GANX
Transactions as of
10 Apr 2023
Net transactions value
$0
Form type
3
Filing time
12 Apr 2023, 17:35:02 UTC

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit List - Exhibit 24 - Power of Attorney